Shenzhen Edge Medical Co., Ltd. (HKG:2675)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
31.06
-0.62 (-1.96%)
Oct 22, 2026, 4:08 PM HKT

Shenzhen Edge Medical Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Shenzhen Edge Medical stock has a consensus rating of "Strong Buy" and an average price target of $56.87. The average 1-year stock price forecast is 83.10% higher than the current stock price, while the lowest is $51.58 (+66.07%) and the highest is $60.23 (+93.92%).

Price Target: $56.87 (+83.10%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$51.58$56.87$56.32$60.23
Change+66.07%+83.10%+81.33%+93.92%
* Price targets were last updated on Sep 14, 2026.

Analyst Ratings

The average analyst rating for Shenzhen Edge Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingApr '26May '26Jul '26Aug '26Sep '26Oct '26
Strong Buy123333
Buy222222
Hold000000
Sell000000
Strong Sell000000
Total345555

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
DBS
DBS
Buy
Maintains
$51.40
BuyMaintains$51.40+65.49%Sep 14, 2026
Unknown Analyst
Huachuang Securities
No rating
Huachuang Securities
Buy
Maintains
$74.00
BuyMaintains$74.00+138.25%Aug 12, 2026
Unknown Analyst
Morgan Stanley
No rating
Morgan Stanley
Buy
Maintains
$75.00
BuyMaintains$75.00+141.47%Jul 3, 2026
Goldman Sachs
Goldman Sachs
Buy
Initiates
$81.00
BuyInitiates$81.00+160.79%Apr 22, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
857.53M
from 455.72M
Increased by 88.17%
Revenue Next Year
1.38B
from 857.53M
Increased by 60.74%
EPS This Year
0.18
from -0.06
EPS Next Year
0.53
from 0.18
Increased by 199.48%
Fiscal YearFY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
48.04M159.99M455.72M857.53M
Revenue Growth
-233.03%184.83%88.17%
Gross Profit
4.56M98.08M300.65M550.53M
Gross Margin
9.49%61.30%65.97%64.20%
Operating Income
-267.44M-283.04M-117.31M112.34M
Net Income
-212.87M-218.51M-88.61M35.20M
EPS
---0.060.18
Forward PE
---150.37
Free Cash Flow
----120.00M
No. Analysts
---5
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High869.0M
Avg857.5M
Low843.0M

Revenue Growth

Revenue Growth202620272028
High
90.7%
Avg
88.2%
Low
85.0%

EPS Forecast

EPS202620272028
High0.25
Avg0.18
Low0.11

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-